News

FDA approves Sandoz hypertension drug

BY Alaric DeArment

PRINCETON, N.J. — The Food and Drug Administration has approved a generic heart-disease drug made by Sandoz, the company said Wednesday.

Sandoz, the generics division of Swiss drug maker Novartis, announced the approval of candesartan cilexetil tablets, a generic version of AstraZeneca’s Atacand.

The drug is used to treat some types of heart failure in adults with left ventricular systolic dysfunction, as well as high blood pressure in adults and children as young as 1.

Atacand had sales of $120.3 million in 2012, according to IMS Health.


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Elan buys Austrian drug maker, stake in Dubai drug maker

BY Alaric DeArment

DUBLIN — Irish drug maker Elan Corp. is paying about $380 million to buy one drug maker and a large stake in another, the company said.

Elan announced plans to buy Vienna-based AOP Orphan Pharmaceuticals for about $340 million, a company that specializes in drugs for rare conditions in a variety of areas, including cancer, neurology and metabolic disorders. Elan also paid an initial $40 million to buy a 48% stake in Newbridge Pharmaceuticals, based in Dubai, United Arab Emirates. Elan will have the option to buy the rest of the company for $244 million by 2015.

"Our proposed package of transactions is designed to create a balance of risk with the benefit of diversification to produce long-term growth in income and value," Elan CEO Kelly Martin said.


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Frajo to distribute, market Coty mass/masstige brands in Brazil’s retail channel

BY Antoinette Alexander

NEW YORK — Coty has announced that it will form a joint venture in Brazil with Brazilian cosmetics distributor Frajo Internacional to distribute and market Coty mass/masstige brands in the retail channel.

"Brazil is one of the largest markets in the beauty industry," stated Michele Scannavini, CEO of Coty. "Frajo is the right partner, sharing our passion for beauty. Together, we look forward to introducing new Coty brands into this key market."

This deal will expand Coty’s go-to-market capabilities in the region. Currently, Coty has an existing commercial partnership in Brazil to distribute certain brands through a door-to-door distribution model. The company also has a distributor representing its Prestige products in the region.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?